An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa biofilms

Microbiology (United Kingdom)

Volumn 162, Issue 10, 2016, Pages 1755-1760

  Harrison, Freya ^a,b   Diggle, Stephen P ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

3Rs; Biofilm; Chronic infection; Cystic fibrosis; Pseudomonas aeruginosa; Respiratory infection

Indexed keywords

ANIMAL TISSUE; ARTICLE; BIOFILM; BRONCHIOLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYSTIC FIBROSIS; EX VIVO STUDY; LUNG INFECTION; LUNG MODEL; NONHUMAN; PIG; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; IN VITRO STUDY; LUNG; MICROBIOLOGY; PHYSIOLOGY; PSEUDOMONAS INFECTION;

ANIMALS; BIOFILMS; BRONCHIOLES; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; HUMANS; IN VITRO TECHNIQUES; LUNG; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SWINE;

EID: 84992694810     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.000352     Document Type: Article

References (29)

1. Benahmed, M. A., Elbayed, K., Daubeuf, F., Santelmo, N., Frossard, N. & Namer, I. J. (2014). NMR HRMAS spectroscopy of lung biopsy samples: comparison study between human, pig, rat, and mouse metabolomics. Magn Reson Med 71, 35-43.
2. Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M. & Høiby, N. (2009). Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 44, 547-558.
3. Bjarnsholt, T., Alhede, M., Alhede, M., Eickhardt-Sørensen, S. R., Moser, C., Kühl, M., Jensen, P. Ø. & Høiby, N (2013). The in vivo biofilm. Trends Microbiol 21, 466-474.
4. Darch, S. E., McNally, A., Harrison, F., Corander, J., Barr, H. L., Paszkiewicz, K., Holden, S., Fogarty, A., Crusz, S. A. & Diggle, S. P. (2015). Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection. Sci Rep 5, 7649.
5. Diaz Caballero, J., Clark, S. T., Coburn, B., Zhang, Y., Wang, P. W., Donaldson, S. L., Tullis, D. E., Yau, Y. C., Waters, V. J. & other authors (2015). Selective sweeps and parallel pathoadaptation drive Pseudomonas aeruginosa evolution in the cystic fibrosis lung. MBio 6, e00981-15.
6. Elborn, J. S. (2016). Cystic fibrosis. Lancet. Advance online publication, 10.1016/S0140-6736(16)00576-6.
7. Harrison, F., Muruli, A., Higgins, S. & Diggle, S. P. (2014). Development of an ex vivo porcine lung model for studying growth, virulence, and signaling of Pseudomonas aeruginosa. Infect Immun 82, 3312-3323.
8. Henderson, A. G., Ehre, C., Button, B., Abdullah, L. H., Cai, L. H., Leigh, M. W., DeMaria, G. C., Matsui, H., Donaldson, S. H. & other authors (2014). Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest 124, 3047-3060.
9. Hoffmann, N. (2007). Animal models of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Drug Discov Today Dis Models 4, 99-104.
10. Kragh, K. N., Alhede, M., Jensen, P. Ø., Moser, C., Scheike, T., Jacobsen, C. S., Seier Poulsen, S., Eickhardt-Sørensen, S. R., Trøstrup, H. & other authors (2014). Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients. Infect Immun 82, 4477-4486.
11. Kukavica-Ibrulj, I. & Levesque, R. C. (2008). Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies. Lab Anim 42, 389-412.
12. LaFayette, S. L., Houle, D., Beaudoin, T., Wojewodka, G., Radzioch, D., Hoffman, L. R., Burns, J. L., Dandekar, A. A., Smalley, N. E. & other authors (2015). Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses. Sci Adv 1, e1500199.
13. Lessells, C. M. & Boag, P. T. (1987). Unrepeatable repeatabilities: a common mistake. The Auk 104, 116-121.
14. McGonigle, P. & Ruggeri, B. (2014). Animal models of human disease: challenges in enabling translation. Biochem Pharmacol 87, 162-171.
15. Meurens, F., Summerfield, A., Nauwynck, H., Saif, L. & Gerdts, V. & Gerdts, V. (2012). The pig: a model for human infectious diseases. Trends Microbiol 20, 50-57.
16. Nunes, S. F., Murcia, P. R., Tiley, L. S., Brown, I. H., Tucker, A. W., Maskell, D. J. &Wood, J. L. N. (2010). An ex vivo swine tracheal organ culture for the study of influenza infection. InfluenzaOther Respir Viruses 4, 7-15.
17. Palmer, K. L., Mashburn, L. M., Singh, P. K. & Whiteley, M. (2005). Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187, 5267-5277.
18. Palmer, K. L., Aye, L. M. & Whiteley, M. (2007). Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189, 8079-8087.
19. Poltak, S. R. & Cooper, V. S. (2011). Ecological succession in longterm experimentally evolved biofilms produces synergistic communities. ISME J 5, 369-378.
20. Roberts, A. E., Kragh, K. N., Bjarnsholt, T. & Diggle, S. P. (2015). The limitations of in vitro experimentation in understanding biofilms and chronic infection. J Mol Biol 427, 3646-3661.
21. Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H. & other authors (2013). Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110, 3507-3512.
22. Short, F. L., Murdoch, S. L. & Ryan, R. P. (2014). Polybacterial human disease: the ills of social networking. Trends Microbiol 22, 508-516.
23. Silva, I. N., Santos, P. M., Santos, M. R., Zlosnik, J. E. A., Speert, D. P., Buskirk, S. W., Bruger, E. L., Waters, C. M., Cooper, V. S. & Moreira, L. M. (2016). Long-term evolution of Burkholderia multivorans during a chronic cystic fibrosis infection reveals shifting forces of selection. mSystems Doi 1, 3.
24. Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P. & other authors (2006). Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103, 8487-8492.
25. Tata, M., Wolfinger, M. T., Amman, F., Roschanski, N., Dötsch, A., Sonnleitner, E., Häussler, S. & Bläsi, U. (2016). RNASeq based transcriptional profiling of Pseudomonas aeruginosa PA14 after short- and long-term anoxic cultivation in synthetic cystic fibrosis sputum medium. PLoS One 11, e0147811.
26. Turner, K. H., Wessel, A. K., Palmer, G. C., Murray, J. L. & Whiteley, M. (2015). Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum. Proc Natl Acad Sci U S A 112, 4110-4115.
27. Tyrrell, J. & Callaghan, M. (2016). Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies. Microbiology 162, 191-205.
28. Wiles, S., Hanage, W. P., Frankel, G. & Robertson, B. (2006). Modelling infectious disease - time to think outside the box? Nat Rev Microbiol 4, 307-312.
29. Williams, P. P. & Gallagher, J. E. (1978). Preparation and long-term cultivation of porcine tracheal and lung organ cultures by alternate exposure to gaseous and liquid medium phases. In Vitro 14, 686-696.